LSQ originated a $25 million invoice finance facility for the U.S. operations of a global pharmaceutical manufacturer.The company was referred to LSQ by a broker partner when the client outgrew its existing line of credit with its bank partner. The...
Read Story
|
Great Rock Capital provided $33 million of capital through a senior secured credit facility to a sponsor-owned pharmaceutical manufacturing and packaging company.
The facility, which includes a revolving line of credit and a term loan, was used to...
Read Story
|
Huntington Business Credit closed a $10,000,000 new credit facility with Capital Wholesale Drug Company on January 26, 2024. Proceeds of the facility were used to refinance existing debt and provide ongoing working capital financing.Capital Wholesale...
Read Story
|
SSG Capital Advisors served as the investment banker to Infinity Pharmaceuticals in the sale of substantially all its assets to a healthcare investment firm. The sale was effectuated through a Chapter 11 Section 363 process in the U.S. Bankruptcy...
Read Story
February 16, 2024, 07:52 AM
|
Journey Medical Corporation announced that the Company has entered into a credit facility with an affiliate of SWK Holdings Corporation, a specialized finance company with a focus on the global healthcare sector, providing for borrowings of up to $20...
Read Story
January 03, 2024, 07:33 AM
|
Verona Pharma plc announced it and its wholly-owned subsidiary, Verona Pharma, have entered into a debt financing facility providing the Company with access to up to $400 million from funds managed by Oxford Finance and Hercules Capital. The debt...
Read Story
January 02, 2024, 07:04 AM
|
Phathom Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal diseases, announced an amendment to its term loan facility from Hercules Capital. Sagard Healthcare is also...
Read Story
December 15, 2023, 07:45 AM
|
Valeo Pharma entered into a credit facility agreement with Accord Financial for a total of $5 million.The credit facility, backed by a first-ranking lien on the company's short-term assets, carries interest at the prime rate plus an applicable margin...
Read Story
September 28, 2023, 07:36 AM
|
Aequum Capital closed an increase to bring the total commitment to $9,000,000 for a revolving credit facility to a Midwest based industry-leading, technology-focused independent online pharmacy. The Company primarily serves the specialty...
Read Story
September 13, 2023, 07:08 AM
|
Rosenthal & Rosenthal announced the completion of a recent $25 million recourse factoring deal for a private equity-owned pharmaceutical and healthcare products company. The company is focused on developing drug-device combination products in the...
Read Story
September 06, 2023, 08:03 AM
|
HLS Therapeutics, a pharmaceutical company focusing on central nervous system and cardiovascular markets, announced an extension to its credit agreement, senior secured term loan, revolver facility and expansion facility with a syndicate of leading...
Read Story
August 14, 2023, 08:10 AM
|
LSQ originated a $30 million credit facility for a New York manufacturer, packager and distributor of pharmaceutical and consumer healthcare products. The company will utilize the facility to diversify its lender group, allowing the company to...
Read Story
|
Bausch Health Companies, a global diversified pharmaceutical company, and KKR announced that Bausch Receivables Funding LP, an Ontario limited partnership and wholly-owned subsidiary of Bausch Health, entered into a $600 million non-recourse...
Read Story
|
MidCap Financial provided a $44 million senior secured credit facility to AleraCare Intermediate, LLC (“AleraCare”). Proceeds from the MidCap Financial credit facility were used to support Hildred Capital Management’s (“Hildred”) acquisition of the...
Read Story
|
MidCap Financial provided a $20 million senior revolving credit facility to ABD Group Inc. (“Village Fertility Pharmacy,” “VFP”). The MidCap credit facility includes an uncommitted option to increase the total facility size up to $35 million....
Read Story
|
Harrow, a leading U.S. eyecare pharmaceutical company, entered into a $100 million secured credit financing agreement with funds managed by Oaktree Capital Management. The interest-only secured credit facility carries an interest rate equal to the...
Read Story
|
Medexus Pharmaceuticals entered into a new senior secured credit agreement agented by BMO. The credit agreement provides for a US$35 million term loan facility and a US$3.5 million revolving loan facility for working capital. The term loan facility...
Read Story
|
Supernus Pharmaceuticals, a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, entered into a credit line agreement with UBS Bank USA (“UBS”) providing the Company...
Read Story
February 15, 2023, 07:30 AM
|
Lighthouse Financial completed a $6 million credit facility to a Tennessee-based manufacturer and distributor of pharmaceutical products. Founded in 2001, the company markets and sells its own branded product lines of enemas, feminine hygiene...
Read Story
January 18, 2023, 07:25 AM
|
Acerus Pharmaceuticals announced that it and its wholly-owned subsidiary, Acerus Pharmaceuticals USA, LLC entered into a US$2 million secured loan agreement with First Generation Capital Inc., a company affiliated with the Chairman of the Board of...
Read Story
December 28, 2022, 07:27 AM
|
Aequum Capital closed a $7,500,000 credit facility to a Midwest based industry-leading technology focused independent online pharmacy.The Company primarily serves the specialty pharmaceutical market and provides better access to specialty medications...
Read Story
December 09, 2022, 08:05 AM
|
Once again, Gibraltar's ability to move swiftly, structure creative financing terms and leverage long-standing relationships resulted in a successful financing partnership.When Prodigy Health, a national drug distributor, was in the process of...
Read Story
December 07, 2022, 07:07 AM
|
Abacus Finance Group served as Senior Secured Credit Facilities Administrative Agent and Sole Lender for senior secured credit facilities to support the leveraged buyout of Pinnacle Clinical Research, LLC by LongueVue Capital. Additionally, Abacus...
Read Story
November 28, 2022, 07:09 AM
|
Tricida entered into a debt facility with Hercules Capital. The total amount of the debt facility is $125 million of which $100 million will be available for drawdown at Tricida’s option subject to the achievement of certain milestones.Under the...
Read Story
October 20, 2022, 08:00 AM
|
HLS Therapeutics announced updates to its credit agreement and senior secured term loan with its existing syndicate of bank lenders co-led by JPMorgan Chase Bank and Silicon Valley Bank. All dollar amounts are stated in U.S. currency.The maturity...
Read Story
October 03, 2022, 07:30 AM
|
Medexus Pharmaceuticals entered into an amendment to the company’s revolving credit facility with a syndicate of lenders agented by MidCap Funding IV Trust (MidCap). Among other things, the amendment provides for a US$5.0 million increase in MidCap’s...
Read Story
September 30, 2022, 07:29 AM
|
BizCap announced it has successfully structured and secured $45 million in financing for its repeat client, Nivagen Pharmaceuticals, a specialty pharmaceuticals company engaged in the development, acquisition and sales of generic prescription drugs...
Read Story
September 27, 2022, 07:39 AM
|
Spectrum Pharmaceuticals entered into a five-year debt financing agreement with investment affiliates managed by SLR Capital Partners, LLC (SLR) for a term loan facility of up to $65 million. The Company believes this transaction, combined with...
Read Story
September 26, 2022, 08:00 AM
|
CIT, a division of First Citizens Bank, announced that its Asset-Based Lending business provided $10 million in financing to Blue Sky Specialty Pharmacy. Based in Charleston, South Carolina, Blue Sky Specialty Pharmacy uses technology to accelerate...
Read Story
September 09, 2022, 07:25 AM
|
Huntington Business Credit closed a $20,000,000 new credit facility with Spirit Pharmaceuticals, LLC on July 6, 2022. Proceeds of the facility were used to refinance existing indebtedness and provide ongoing working capital growth...
Read Story
August 09, 2022, 08:06 AM
|
White Oak Healthcare Finance acted as sole lender and administrative agent of a senior credit facility to California Specialty Pharmacy (“CSP” or the “Company”) to support the acquisition by Assured Healthcare Partners (“AHP”). CSP is a specialty...
Read Story
|
Oxford Finance closed a $75 million senior secured term loan with Fusion Pharmaceuticals Inc., a clinical-stage oncology company focused on developing next-generation radiopharmaceuticals as precision medicines to treat a broad range of...
Read Story
|
Marinus Pharmaceuticals received $30 million in funding under the existing Oaktree Capital Management credit agreement. This additional funding became available as a result of the U.S. Food and Drug Administration’s (FDA) recent approval of the...
Read Story
|
Lexicon Pharmaceuticals entered into a loan facility with Oxford Finance that provides up to $150 million in borrowing capacity designed primarily to support commercial preparations and the potential launch of sotagliflozin in heart failure.The loan...
Read Story
|
EyePoint Pharmaceuticals entered into a loan agreement providing for senior secured credit facilities in the aggregate amount of $45 million with Silicon Valley Bank to replace its existing credit facility with CRG Servicing LLC. Under the terms of...
Read Story
|
Innocoll Biotherapeutics, a specialty pharmaceutical company and portfolio business of Gurnet Point Capital, successfully refinanced its existing term loan facility with a new $125 million term loan provided by funds managed by Oaktree Capital...
Read Story
January 31, 2022, 07:36 AM
|
Siena Healthcare Finance recently provided a $12 million working capital facility for a private equity backed, multi-state provider of specialty pharmaceutical, infusion and nutritional therapy services for patients with chronic illnesses and health...
Read Story
September 29, 2021, 07:40 AM
|
Harrow Health, an ophthalmic-focused healthcare company, and Melt Pharmaceuticals, a clinical-stage pharmaceutical company developing first-in-class medicines for sedation and analgesia, announced that Harrow Health has provided a $13.5 million...
Read Story
September 07, 2021, 07:24 AM
|
Colbeck Capital Management provided $125 million in financing to Woodward Pharma Services, LLC ("Woodward") and its affiliate Future Pak Ltd. ("Future Pak").Woodward and Future Pak, headquartered in Wixom, MI, are headed by industry veterans, David...
Read Story
August 16, 2021, 07:08 AM
|
Harmony Biosciences Holdings, a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases, and Blackstone entered into a strategic financing collaboration where funds managed...
Read Story
August 12, 2021, 07:06 AM
|
4D pharma plc closed a senior secured credit facility for up to $30MM with Oxford Finance LLC.“The credit facility from Oxford Finance provides access to additional capital strengthening our financial position and increasing our financial flexibility...
Read Story
|
Impel NeuroPharma closed a $50 million debt facility with Oxford Finance and Silicon Valley Bank, of which the first $20 million was funded at closing.“This strategic debt financing, coupled with our current cash, increases our balance sheet strength...
Read Story
|
Oxford Finance closed a $125 million senior secured term loan with Kala Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for diseases of the eye.Proceeds from the...
Read Story
|
Acerus Pharmaceuticals Corporation entered into an amended agreement related to its existing credit facility with SWK Funding LLC, a subsidiary of SWK Holdings Corporation.The nature of the amendments are to: i) set principal repayment at US$1.1...
Read Story
|
Pitney Bowes announced that the Pitney Bowes Bank has signed a term loan and accompanying revolving line of credit, demonstrating its continued commitment to the small- and mid-market business community. The term loan was signed with pharmaceutical...
Read Story
February 22, 2021, 07:00 AM
|
Oxford Finance announced the closing of a $122 million senior credit facility to Tarrytown Expocare, a closed-door long-term care pharmacy specializing in serving individuals with intellectual and developmental disabilities (“IDD”).Proceeds from the...
Read Story
January 15, 2021, 07:55 AM
|
Capital One announced that it served as administrative agent and lead arranger for an amended and restated credit facility totaling approximately $960 million for Covis Group S.á.r.l. This includes a $485 million upsize to its existing facility in...
Read Story
November 18, 2020, 08:57 AM
|
Scholar Rock, a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, announced the closing of a $50 million debt facility with Silicon Valley Bank and Oxford...
Read Story
October 19, 2020, 08:45 AM
|
Athenex, Inc., a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, today announced that it has entered into a $225 million loan...
Read Story
|
According to an article authored by Michael Gibney, Healthcare Reporter, S&P Global Market Intelligence and published by S&P Global Market Intelligence on June 15, 2020, for some biotech and pharmaceutical companies ready to send new drugs out into...
Read Story
|
Albireo Pharma, Inc., a clinical-stage orphan pediatric liver disease company developing novel bile acid modulators, today announced it has agreed to terms with Hercules Capital, Inc. on a debt facility to provide up to $80 million of new capital...
Read Story
|
Analysis by Tiger Liquidity Services Biopharma Partnership underscores the strategic value to hedge funds, private equity firms, asset-based lenders, and bankruptcy professionals of leveraging asset-valuation and disposition in the...
Read Story
|
Baudax Bio, Inc., a pharmaceutical company focused on therapeutics for acute care settings, today announced that it has closed on a credit facility of up to $50 million from funds managed by Marathon Asset Management, a global credit solutions...
Read Story
|
Business Capital structured and delivered an $8M secured asset based credit facility for Nivagen Pharmaceuticals, a specialty company that develops and sells generic prescription drugs for the North American market. Nivagen is focused on building a...
Read Story
|
White Oak Healthcare Finance, LLC announced that it acted as sole lender and administrative agent on a senior credit facility for Virtus Pharmaceuticals, a portfolio company of Linden Capital Partners (“Linden”). Proceeds were used to refinance...
Read Story
December 04, 2019, 08:55 AM
|
Arranta Bio announced the completion of an $82 million funding round and a strategic partnership with Thermo Fisher Scientific.Formed in May 2019, Arranta's goal is to be the best-in-class microbiome contract development and manufacturing...
Read Story
October 30, 2019, 08:45 AM
|
Encina Business Credit, LLC (EBC) announced that it has provided a $25 million senior secured credit facility to a pharmaceutical company. The company is focused on developing, manufacturing, and commercializing its three patented products, which aim...
Read Story
October 07, 2019, 08:45 AM
|
Kindred Biosciences, Inc., a commercial-stage biopharmaceutical company focused on saving and improving the lives of pets, announced the closing of a $50 million senior secured debt facility with investment affiliates managed by Solar Capital...
Read Story
October 07, 2019, 08:00 AM
|
Speritas Capital Partners announced the closing of a $27 million asset-based revolving line of credit for a major plastics manufacturer. Speritas Capital was brought in by the client to assess financing options to pay off their current lender and to...
Read Story
September 13, 2019, 08:03 AM
|
Foamix Pharmaceuticals Ltd., a clinical stage specialty pharmaceutical company focused on developing and commercializing proprietary topical therapies to address unmet needs in dermatology, announced that it has secured up to $64 million in financing...
Read Story
|
AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings, announced the closing of a $25 million senior secured debt facility...
Read Story
|
Aerie Pharmaceuticals, Inc. (Aerie), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other...
Read Story
|
LBC Credit Partners provided a term loan to BioMatrix Specialty Pharmacy, LLC, a portfolio company of ACON Investments, L.L.C., (ACON) to refinance existing debt and to support an add-on acquisition.BioMatrix Specialty Pharmacy, LLC offers...
Read Story
|
Achaogen, Inc., a biopharmaceutical company developing and commercializing innovative antibacterial agents to address multi-drug resistant (MDR) gram-negative infections, announced that it has filed a voluntary petition under Chapter 11 of the...
Read Story
|
Tricida, Inc., a pharmaceutical company focused on the development and commercialization of its drug candidate TRC101 (veverimer), a non-absorbed, orally-administered polymer designed to treat metabolic acidosis in patients with chronic kidney...
Read Story
|
Facing nearly 2,000 lawsuits for its alleged role in facilitating America’s overdose crisis, Purdue Pharma – maker of the narcotic painkiller OxyContin – is reportedly considering filing for Chapter 11 bankruptcy, according to sources cited by...
Read Story
|
Recro Pharma, Inc., a revenue generating specialty pharmaceutical company focused on therapeutics for hospitals and other acute care settings, announced that it has closed on an amended and expanded $125 million credit facility with investment funds...
Read Story
|
CIT Group announced that its Healthcare Finance unit served as joint lead arranger and administrative agent on the first-lien credit facility for the acquisition of KabaFusion, a leading provider of acute and specialty home infusion services, by...
Read Story
February 19, 2019, 10:09 AM
|
Aimmune Therapeutics, Inc., a biopharmaceutical company developing treatments for potentially life-threatening food allergies, announced that it has entered into a $170 million loan agreement with an affiliate of KKR, a leading global investment firm...
Read Story
January 07, 2019, 07:20 AM
|
Bristol-Myers Squibb Company and Burgundy Merger Sub, Inc., a wholly owned subsidiary of BMS, entered into an Agreement and Plan of Merger with Celgene Corporation (Celgene). The Merger Agreement provides, among other things, that on the terms and...
Read Story
January 04, 2019, 09:00 AM
|
ANI Pharmaceuticals, Inc. announced that it has entered an amended and restated five-year Senior Secured Credit Facility for up to $265.2 million with its existing syndicate of bank lenders. The Facility amends ANI's current $125 million Senior...
Read Story
December 28, 2018, 08:32 AM
|
Walgreens Boots Alliance, Inc., the largest retail pharmacy, health and daily living destination across the U.S. and Europe, entered into a revolving credit agreement with the lenders from time to time party thereto and Bank of America, N.A., as...
Read Story
December 26, 2018, 08:10 AM
|
Nabriva Therapeutics plc, a clinical stage biopharmaceutical company engaged in the research and development of novel anti-infective agents to treat serious infections, announced the closing of up to a $75 million term loan with Hercules Capital, Inc...
Read Story
December 21, 2018, 08:00 AM
|
Capital One announced that it served as administrative agent and lead arranger for a $350 million senior credit facility for Covis Pharma B.V. (Covis). The facility consists of a $25 million revolver and a $325 million term loan that Covis used to...
Read Story
December 13, 2018, 07:15 AM
|
Synergy Pharmaceuticals Inc., a biopharmaceutical company focused on the development and commercialization of novel gastrointestinal (GI) therapies, announced an agreement with Bausch Health Companies Inc., through which Bausch Health would acquire...
Read Story
December 12, 2018, 07:06 AM
|
Tiger Group and Liquidity Services, Inc. announced the launch of a partnership focused on rapid, efficient and high-recovery disposition of assets from distressed organizations in the biopharmaceutical manufacturing industry.
Tiger Liquidity...
Read Story
November 14, 2018, 08:13 AM
|
Monroe Capital LLC announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the majority recapitalization of SMP Pharmacy Solutions (SMP) by private equity sponsor, Galen Partners. Based...
Read Story
August 07, 2018, 07:09 AM
|
Acacia Pharma Group plc, a hospital pharmaceutical company focused on the development and commercialization of new nausea & vomiting treatments for surgical and cancer patients, has secured a credit facility of up to $30 million with Hercules...
Read Story
|
pSivida Corp., a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, announced the acquisition of Icon Bioscience Inc. (Icon). Icon is a specialty biopharmaceutical company whose lead...
Read Story
|
Charles River Laboratories International, Inc. announced that it has refinanced its existing $1.0 billion of revolving credit facility due 2021 with a new $1.55 billion revolving credit facility due 2023, and its existing $650.0 million of term loan...
Read Story
|
Orexigen Therapeutics, Inc., a biopharmaceutical company focused on the treatment of obesity, announced that it has elected to file a voluntary petition under Chapter 11 of the Bankruptcy Code in the U.S. Bankruptcy Court for the District of Delaware...
Read Story
|
Achaogen, Inc., a late-stage biopharmaceutical company developing innovative antibacterials addressing multi-drug resistant (MDR) gram-negative infections, has entered into a new secured credit facility with Silicon Valley Bank (SVB), the bank of the...
Read Story
|
Mallinckrodt has entered into a $600 million senior secured term loan facility to help finance its merger with Sucampo Pharmaceuticals, Inc., according to a regulatory filing. The New Term Loan is an incremental facility under the Credit Agreement...
Read Story
February 14, 2018, 07:15 AM
|
Super G announced the company provided a $2.0 million senior secured, interest-only bridge loan for a private equity backed, outsourced pharmaceutical service provider conducting clinical research. The senior secured, interest-only bridge loan was...
Read Story
January 25, 2018, 07:03 AM
|
Pharmaceutical Research Associates, Inc., a Virginia corporation (PRA) and a wholly-owned subsidiary of PRA Health Sciences, Inc., entered into a First Amendment and Second Joinder Agreement to the Credit Agreement, dated as of December 6, 2016 with...
Read Story
January 02, 2018, 07:00 AM
|
Recro Pharma, Inc., a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, announced that it has secured a $100 million credit facility from funds managed by Athyrium Capital...
Read Story
November 21, 2017, 07:09 AM
|
Motif Bio plc, a clinical stage biopharmaceutical company specializing in developing novel antibiotics, announced that the company has entered into an agreement for up to $20 million in debt financing with Hercules Capital, Inc. a provider of debt...
Read Story
November 15, 2017, 07:01 AM
|
Teva Pharmaceutical Industries Ltd., announced amendments to its USD and JPY term loan and revolving credit facilities, providing Teva greater flexibility in its financial leverage ratio covenants. The amended leverage ratio covenants in the credit...
Read Story
September 20, 2017, 07:10 AM
|
Synergy Pharmaceuticals Inc. announced that the company has closed on a $300 million debt financing structured as senior secured loans from CRG LP, a healthcare focused investment firm, and its lender syndicate.“This non-dilutive financing enhances...
Read Story
September 06, 2017, 07:09 AM
|
Sarepta Therapeutics, Inc., a U.S. commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment of rare neuromuscular diseases, announced that it has entered into credit and...
Read Story
|
Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that it has entered into a $50 million senior...
Read Story
|
Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $15 million credit facility to new client Unum Therapeutics, a clinical stage biopharmaceutical company developing cellular immunotherapies for the treatment of many...
Read Story
|
BioDelivery Sciences International, Inc. announced that it has entered into a senior credit facility with affiliates of CRG LP, a healthcare-focused investment firm, to retire its existing credit facility and provide additional working capital for...
Read Story
February 24, 2017, 07:25 AM
|
Eagle Pharmaceuticals, Inc., announced it has entered into a Credit Agreement with JPMorgan Chase Bank, N.A., as administrative agent and the lenders party thereto.
The Credit Agreement provides for a three-year $50 million revolving credit facility...
Read Story
February 01, 2017, 07:18 AM
|
Endoceutics, Inc., a private Quebec City based biopharma company, announced that it has entered into a long-term $85 million senior credit facility with CRG LP, a healthcare-focused investment firm. The proceeds will support the commercial launch of...
Read Story
January 12, 2017, 07:15 AM
|
Strongbridge Biopharma plc, a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs, announced that it closed its previously announced $35...
Read Story
January 03, 2017, 07:15 AM
|
Sorrento Therapeutics, Inc., an antibody-centric, clinical-stage biopharmaceutical company developing new treatments for cancer and other unmet medical needs, announces it has entered into a loan and security agreement with Hercules Capital, Inc. for...
Read Story
November 29, 2016, 07:23 AM
|
ESSA Pharma Inc., a pharmaceutical company focused on the development of small molecule drugs for the treatment of prostate cancer, announced that it has secured a US$10 million growth capital term loan facility from Silicon Valley Bank ("SVB" or the...
Read Story
November 22, 2016, 07:22 AM
|
Horizon Technology Finance Corporation announced that Horizon and Silicon Valley Bank (“SVB”), have provided a $25 million venture loan facility for vTv Therapeutics Inc., a clinical-stage biopharmaceutical company committed to the discovery and...
Read Story
November 16, 2016, 07:22 AM
|
Omeros Corporation has entered into a senior credit facility with CRG LP, a healthcare-focused investment firm, to retire the company’s existing credit facility, minimizing restricted cash requirements and providing additional working capital for its...
Read Story
October 28, 2016, 07:06 AM
|
Monroe Capital announced it acted as sole lead arranger and administrative agent on the funding of a senior credit facility to support the acquisition of ProPharma Group by private equity sponsor, Linden Capital Partners. Founded in 2001 and based in...
Read Story
October 06, 2016, 07:21 AM
|
BioCryst Pharmaceuticals, Inc. has closed a $23 million senior credit facility with MidCap Financial. The facility was fully funded at closing and bears a variable interest rate based upon LIBOR, currently at 8.5%; an interest-only period through...
Read Story
September 26, 2016, 08:11 AM
|
Square 1 Bank, a division of Pacific Western Bank, announced that it has provided a $10 million credit facility to new client Zavante Therapeutics, a clinical-stage biotechnology company. Proceeds from the facility will provide growth capital to...
Read Story
September 01, 2016, 07:25 AM
|
Aprecia Pharmaceuticals Company, a commercial stage pharmaceutical company developing, manufacturing and marketing fast melt formulations of high dose pharmaceuticals, today announced that it has entered into an up to $30 million debt financing...
Read Story
|
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced today that the company has entered into a $140 million debt facility agreement with CRG LP to retire an existing debt...
Read Story
|
ANI Pharmaceuticals, Inc. announced that it has entered a new three-year senior secured asset-based revolving credit facility for up to $30 million. This facility will be secured by inventory and certain other working capital and related assets of...
Read Story
|
Neos Therapeutics, Inc., a pharmaceutical company focused on developing and commercializing innovative extended-release (XR) products for the treatment of attention-deficit/hyperactivity disorder (ADHD),announced the closing of a $60 million term...
Read Story
|
Relypsa, Inc., a biopharmaceutical company, today announced the closing of $150 million in aggregate principal amount of senior secured term loans (the "Loans"), led by funds advised by Athyrium Capital Management and joined by HealthCare Royalty...
Read Story
|
Oxford Finance announced the closing of a senior credit facility with Diversis Capital, LLC, a private equity firm focused on acquiring and growing small- and middle-market companies. Oxford was the sole lender and administrative agent for this...
Read Story
|
CIT Group announced that CIT Healthcare Finance served as lead arranger for a $190 million senior secured credit facility to help finance the combination of Vertical/Trigen Holdings, LLC (Vertical/Trigen) with Osmotica Holdings Corp Limited...
Read Story
February 12, 2016, 07:28 AM
|
CytRx Corporation, a biopharmaceutical research and development company specializing in oncology, has entered into a long-term loan and security agreement with Hercules Technology Growth Capital, Inc. and Hercules Technology III, L.P. for up to $40...
Read Story
February 09, 2016, 07:27 AM
|
Thompson Street Capital Partners (TSCP), in partnership with Arsenal Capital Partners, a New York City-based management and investment firm, announced today that they have recapitalized BioreclamationIVT. The new partnership will provide additional...
Read Story
January 20, 2016, 07:09 AM
|
Acorda Therapeutics, Inc. entered into an agreement to acquire Biotie Therapies Corp. for €23.5680 per ADS in cash, or the equivalent of $25.60 per ADS based on an exchange rate of 1.0864 U.S. dollars to euros, which values Biotie at approximately...
Read Story
January 19, 2016, 08:06 AM
|
NXT Capital announced that it has provided a senior secured credit facility to refinance WellSpring Pharmaceutical Corporation. WellSpring is a portfolio company of Sentinel Capital Partners and Ancor Capital Partners. The transaction included...
Read Story
January 05, 2016, 08:13 AM
|
Pernix Therapeutics Holdings, a specialty pharmaceutical company, today announced the completion of a new three-year $50 million revolving credit facility with Wells Fargo. The new facility bears an interest rate of LIBOR plus 1.5% to LIBOR plus 2.0%...
Read Story
August 25, 2015, 07:19 AM
|
Flexion Therapeutics, Inc. entered into a syndicated senior secured term loan facility with MidCap Financial and Silicon Valley Bank that allows Flexion to borrow up to $30 million at an annual interest rate of 6.25 percent with a maturity of...
Read Story
August 05, 2015, 07:28 AM
|
Ocera Therapeutics secured a $20 million debt facility from Oxford Finance and Silicon Valley Bank (SVB). Ocera intends to use the additional capital to support the ongoing development of the company's novel molecule OCR-002 to treat acute and...
Read Story
|
Zosano Pharma Corporation has secured $15.0 million in debt financing through Hercules Technology Growth Capital, Inc. Zosano amended its existing secured-term loan facility with Hercules to increase the total loan amount to $15.0 million, with an...
Read Story
|
ADMA Biologics, Inc., a late-stage biopharmaceutical company developing specialty plasma-based biologics for the treatment and prevention of certain infectious diseases, announced that it has entered into a loan and security agreement with Oxford...
Read Story
|
BioDelivery Sciences International, Inc. has secured an additional $20.7 million in gross debt funding from MidCap Financial to bring BDSI's total outstanding debt with MidCap to $30 million in a single senior secured loan. The proceeds of the loan...
Read Story
|
Oxford Finance LLC, a specialty finance firm that provides senior debt to life sciences and healthcare services companies, announced the closing of a $5 million expansion to an existing $10 million senior secured term loan agreement with Edgemont...
Read Story
|
Monroe Capital LLC announced it acted as sole lead arranger and administrative agent on the funding of a $14.5 million senior credit facility to support the recapitalization and growth of Precision Toxicology, LLC by private equity sponsor, BelHealth...
Read Story
|
Depomed, Inc. has entered into a definitive agreement with Deerfield and Pharmakon Advisors, LP to borrow $575 million. The proceeds of the loan will be used to fund the acquisition of the U.S. rights to the NUCYNTA franchise from Janssen...
Read Story
|
Agile Therapeutics, Inc., a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, announced that it has entered into a loan and security agreement with Hercules...
Read Story
February 25, 2015, 07:10 AM
|
GE Capital’s Healthcare Financial Services (HFS) business announced today that it is serving as administrative agent and collateral agent on a $250 million term loan financing for Amneal Pharmaceuticals LLC. This term loan will be pari passu with a...
Read Story
February 11, 2015, 07:13 AM
|
Trevi Therapeutics, Inc., a late-stage clinical development company focused on developing Nalbuphine ER for chronic pruritus conditions, announced the closing of a $15 million senior secured term loan agreement provided by Solar Capital Ltd. as...
Read Story
January 09, 2015, 07:24 AM
|
Dynavax Technologies Corporation announced that the company has entered into a credit facility with Hercules Technology Growth Capital, Inc. for up to $40 million of total funding. Dynavax drew the first tranche of $10 million on closing and has...
Read Story
December 29, 2014, 07:52 AM
|
Palatin Technologies, Inc., a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential, announced that it has closed on a private...
Read Story
December 29, 2014, 07:24 AM
|
ScripsAmerica, Inc. announced that the company has secured a $4 million line of credit from Triumph Healthcare Finance. The line of credit will be used by ScripsAmerica to fund the expansion of its specialty pharmacy operations in the US and pay off...
Read Story
December 11, 2014, 07:41 AM
|
MidCap Financial served as joint lead arranger, joint bookrunner and syndication agent for a $65 million senior secured credit facility in support of the acquisition of Celerion, Inc. by MTS Health Investors, LLC ("MTS").MidCap's Leveraged Loan &...
Read Story
November 18, 2014, 08:01 AM
|
BMO Harris Bank’s Sponsor Finance group announced it was joint lead arranger, joint bookrunner and administrative agent for $65 million in senior secured credit facilities to Celerion, Inc., an MTS Health Investors portfolio company Celerion is a...
Read Story
November 04, 2014, 07:29 AM
|
Argos Therapeutics, Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis™ technology platform, announced that it...
Read Story
October 01, 2014, 06:57 AM
|
PharMerica Corporation, a national provider of institutional specialty home infusion hospital and oncology pharmacy services, announced that it has successfully closed on a new credit agreement. PharMerica will use the facilities for general...
Read Story
September 22, 2014, 07:54 AM
|
Trevena, Inc. has entered into a senior secured term loan credit facility providing for up to $35 million of funding, of which $2 million was drawn at closing. Trevena has the option to draw the remaining funds in two equal tranches upon positive...
Read Story
September 22, 2014, 07:49 AM
|
Cardiome Pharma Corp. announced today the closing of a senior, secured term loan facility of up to $22 million to be made available to the company by MidCap Financial, LLC in two tranches with an interest rate of Libor plus 8%.Cardiome currently...
Read Story
|
ZS Pharma, a biopharmaceutical company developing novel treatments for kidney, cardiovascular, liver and metabolic disorders, today announced that it has secured a debt facility of up to $20 million with MidCap Financial. The company will use the...
Read Story
|
DURECT Corporation announced that it had entered into a Loan and Security Agreement (the "Loan Agreement") with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the company in the principal amount of $20 million. The loan...
Read Story
|
Horizon Pharma, Inc. announced that it has entered into an agreement with a group of lenders to provide Horizon with $300 million in financing through a five year senior secured credit facility. Funding is expected to occur coincident with the...
Read Story
|
RuiYi, Inc., a global therapeutic innovation leader, announced the close of a $4 million debt financing from Silicon Valley Bank to advance a pipeline of novel monoclonal antibodies (mAb) targeting G protein coupled receptors (GPCRs). RuiYi plans to...
Read Story
|
Evoke Pharma, Inc., a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, announced that it has secured a $4.5 million term loan agreement with Square 1 Bank. In advance of this transaction, Evoke repaid the...
Read Story
|
Alimera Sciences, Inc., a biopharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals, announced today that its United Kingdom subsidiary, Alimera Sciences Limited (Limited)...
Read Story
|
Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced the closing of a $20 million term loan with with Zafgen, Inc. The funds were provided to Zafgen from...
Read Story
|
Concordia Healthcare Corp. has entered into a definitive agreement to acquire Donnatal, an adjunctive therapy in the treatment of irritable bowel syndrome ("IBS") and acute enterocolitis, from a privately held specialty pharmaceutical company...
Read Story
|
Omeros Corporation closed a senior credit facility with Oxford Finance and MidCap Financial consisting of a $32 million term loan, which requires interest-only payments through March 2015. Thereafter, monthly principal and interest payments will be...
Read Story
|
ADMA Biologics, Inc. announced it has secured a loan commitment for up to $15 million from Hercules Technology Growth Capital, Inc., a leading specialty finance company focused on providing senior secured loans to venture capital-backed companies in...
Read Story
February 28, 2014, 07:19 AM
|
Pernix Therapeutics Holdings, Inc. announced that it has closed on the issuance of $65 million aggregate principal amount of 8.00% Convertible Senior Notes due 2019 (the “Notes”) to a group of institutional investors led by Athyrium Capital...
Read Story
February 26, 2014, 07:05 AM
|
On January 23, 2014, Jazz Pharmaceuticals, as guarantor, and three of its wholly-owned subsidiaries, Jazz Pharmaceuticals, Inc. (the "U.S. Borrower"), Jazz Financing I Limited and Jazz Pharmaceuticals Ireland Limited, as borrowers (collectively with...
Read Story
January 24, 2014, 07:07 AM
|
Acura Pharmaceuticals, Inc. entered into a Loan and Security Agreement with Oxford Finance LLC, pursuant to which Oxford agreed to make a term loan to the Company in the principal amount of $10.0 million. The loan has a fixed interest rate of 8.35%...
Read Story
December 31, 2013, 07:56 AM
|
Amicus Therapeutics, a biopharmaceutical company at the forefront of therapies for rare and orphan diseases, has completed a $25 million long-term debt financing with a lending syndicate consisting of MidCap Financial, LLC, Oxford Finance LLC, and...
Read Story
December 30, 2013, 08:04 AM
|
AcelRx Pharmaceuticals has entered into a new amended and restated credit facility with Hercules Technology Growth Capital, Inc. that extends AcelRx's current relationship with Hercules, which was established in June 2011. The new Hercules credit...
Read Story
December 20, 2013, 07:19 AM
|
Lannett Company, Inc. has established a new, five-year $50 million revolving credit facility with a syndicate of two lenders, Citibank, N.A., as administrative agent, and PNC Bank, National Association. Lannett expects to use the credit facility for...
Read Story
December 20, 2013, 07:13 AM
|
Iroko Pharmaceuticals, LLC, a global specialty pharmaceutical company dedicated to advancing the science of analgesia, announced that the company has entered into a $75 million debt facility agreement with an affiliate of OrbiMed Advisors LLC to...
Read Story
November 22, 2013, 07:23 AM
|
Auxilium Pharmaceuticals, Inc., a specialty biopharmaceutical company, entered into an Incremental Assumption Agreement ("Incremental Agreement") with Morgan Stanley Senior Funding, Inc. ("MSSF") under its existing Credit Agreement with MSSF. Under...
Read Story
September 20, 2013, 07:16 AM
|
Akorn Inc., a maker of generic eye-care products, obtained $675 million of financing commitments backing its purchase of Hi-Tech Pharmacal Co. The credit pact consists of a $600 million term loan and a $75 million revolving credit line, according to...
Read Story
August 29, 2013, 07:48 AM
|
Prospect Capital Corporation has provided $80.0 million of floating-rate first-lien senior-secured loans and a senior-secured revolving credit facility for the recapitalization of Matrixx Initiatives, Inc., owner of Zicam, a leading developer and...
Read Story
August 12, 2013, 07:31 AM
|
Cole Taylor Business Capital, a division of Cole Taylor Bank, recently announced the funding of a $12 million facility for PureTek Corporation. The company, located in San Fernando, CA, is a manufacturer and distributor of pharmaceuticals...
Read Story
|
Anthera Pharmaceuticals, a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, secured a new $20.0 million debt financing facility through a syndicate led by MidCap Financial. Anthera will use the loan...
Read Story
|